Literature DB >> 7490113

Oestrogen influences CD4+ T-lymphocyte activity in vivo and in vitro in beta 2-microglobulin-deficient mice.

D Muller1, M Chen, A Vikingsson, D Hildeman, K Pederson.   

Abstract

Oestrogen directly influences autoimmune diseases and the immune response to microbes. We studied the effect of oestrogen on CD4+ T cells specific for lymphocytic choriomeningitis virus (LCMV) using mice genetically engineered to be deficient in beta 2-microglobulin (beta 2m-/-). These mice are deficient in beta 2-microglobulin, class I major histocompatibility complex (MHC) molecules and CD8+ T lymphocytes. Fatal leptomeningitis after intracranial infection with LCMV is mediated by CD8+ cytotoxic T lymphocytes (CTL) in wild-type C57BL/6 mice, and by CD4+ T cells in beta 2m-/- mice. Male and female wild-type C57BL/6 mice showed equal susceptibility to immune meningitis. In contrast, male beta 2m-/- mice were less susceptible to fatal immune meningitis than were females. Orchidectomy and oestrogen treatment of male beta 2m-/- mice in vivo restored susceptibility to meningitis. The classic weight loss seen in beta 2m-/- mice after intracranial infection was also accentuated in females. Further, the in vitro activity of CD4+ T cells from male beta 2m-/- mice, as measured by CTL assays, was shown to be dependent on oestrogen. The natural killer cell activity of spleen cells from beta 2m-/- mice after infection with LCMV was not affected by oestrogen. These data demonstrate the influence of oestrogen on CD4+ T-cell activity both in vivo and in vitro.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7490113      PMCID: PMC1383990     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  26 in total

1.  Is suppression a function of class II--restricted cytotoxic T cells?

Authors:  A Lanzavecchia
Journal:  Immunol Today       Date:  1989-05

2.  Normal development of mice deficient in beta 2M, MHC class I proteins, and CD8+ T cells.

Authors:  B H Koller; P Marrack; J W Kappler; O Smithies
Journal:  Science       Date:  1990-06-08       Impact factor: 47.728

3.  Interactions between the gonadal steroids and the immune system.

Authors:  C J Grossman
Journal:  Science       Date:  1985-01-18       Impact factor: 47.728

4.  Hormonal influence on experimental infections by a toxic shock strain of Staphylococcus aureus.

Authors:  G K Best; T O Abney; J M Kling; J J Kirkland; D F Scott
Journal:  Infect Immun       Date:  1986-04       Impact factor: 3.441

5.  Cytolytic T lymphocytes from the BALB/c-H-2dm2 mouse recognize the vesicular stomatitis virus glycoprotein and are restricted by class II MHC antigens.

Authors:  M J Browning; A S Huang; C S Reiss
Journal:  J Immunol       Date:  1990-08-01       Impact factor: 5.422

6.  Enhanced virus replication and inhibition of lymphocytic choriomeningitis virus disease in anti-gamma interferon-treated mice.

Authors:  T P Leist; M Eppler; R M Zinkernagel
Journal:  J Virol       Date:  1989-06       Impact factor: 5.103

Review 7.  Sex steroids, glucocorticoids, stress and autoimmunity.

Authors:  F Homo-Delarche; F Fitzpatrick; N Christeff; E A Nunez; J F Bach; M Dardenne
Journal:  J Steroid Biochem Mol Biol       Date:  1991       Impact factor: 4.292

8.  Regulation of the immune response by sex hormones. I. In vitro effects of estradiol and testosterone on pokeweed mitogen-induced human B cell differentiation.

Authors:  Z M Sthoeger; N Chiorazzi; R G Lahita
Journal:  J Immunol       Date:  1988-07-01       Impact factor: 5.422

9.  Protection against acute lethal viral infections with the native steroid dehydroepiandrosterone (DHEA).

Authors:  R M Loria; T H Inge; S S Cook; A K Szakal; W Regelson
Journal:  J Med Virol       Date:  1988-11       Impact factor: 2.327

10.  Effect of castration and sex hormone treatment on survival, anti-nucleic acid antibodies, and glomerulonephritis in NZB/NZW F1 mice.

Authors:  J R Roubinian; N Talal; J S Greenspan; J R Goodman; P K Siiteri
Journal:  J Exp Med       Date:  1978-06-01       Impact factor: 14.307

View more
  8 in total

1.  Androgens suppress antigen-specific T cell responses and IFN-γ production during intracranial LCMV infection.

Authors:  Adora A Lin; Sara E Wojciechowski; David A Hildeman
Journal:  J Neuroimmunol       Date:  2010-09-14       Impact factor: 3.478

2.  Gamma interferon signaling in macrophage lineage cells regulates central nervous system inflammation and chemokine production.

Authors:  Adora A Lin; Pulak K Tripathi; Allyson Sholl; Michael B Jordan; David A Hildeman
Journal:  J Virol       Date:  2009-06-10       Impact factor: 5.103

3.  Vaccination against persistent viral infection exacerbates CD4+ T-cell-mediated immunopathological disease.

Authors:  D Hildeman; D Yañez; K Pederson; T Havighurst; D Muller
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

4.  Normal development of thymus in male and female mice requires estrogen/estrogen receptor-alpha signaling pathway.

Authors:  S Yellayi; C Teuscher; J A Woods; T H Welsh; K S Tung; M Nakai; C S Rosenfeld; D B Lubahn; P S Cooke
Journal:  Endocrine       Date:  2000-06       Impact factor: 3.633

Review 5.  Tolerance to noninherited maternal antigens in mice and humans.

Authors:  Partha Dutta; William J Burlingham
Journal:  Curr Opin Organ Transplant       Date:  2009-08       Impact factor: 2.640

6.  Peripheral blood lymphocyte subsets in adolescents: a longitudinal analysis from the REACH project.

Authors:  Bret J Rudy; Craig M Wilson; Stephen Durako; Anna-Barbara Moscicki; Larry Muenz; Steven D Douglas
Journal:  Clin Diagn Lab Immunol       Date:  2002-09

7.  Immune phenotype of chronic liver disease.

Authors:  A J Czaja; R M dos Santos; A Porto; P J Santrach; S B Moore
Journal:  Dig Dis Sci       Date:  1998-09       Impact factor: 3.199

Review 8.  Gender and risk of autoimmune diseases: possible role of estrogenic compounds.

Authors:  S A Ahmed; B D Hissong; D Verthelyi; K Donner; K Becker; E Karpuzoglu-Sahin
Journal:  Environ Health Perspect       Date:  1999-10       Impact factor: 9.031

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.